FRANCIS RICHARD D (President and CEO) sold 0.5% of their position (6.15K shares) of TEVA PHARMACEUTICAL INDUSTRIES LTD on the open market
Open‑market sale worth $211.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/8/2026ACC: 0001193125-26-261660
Officer· President and CEO
Since Mar 2026
-6.15K
Net shares
Net seller
$211.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
13.04K acquired · 19.20K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+13.04K
Price / share
—
Trade value
—
% of position
1.1%
6/5/2026
1.17M→1.18M
Ordinary Shares
Direct
Shares
−6.15K
Price / share
$34.35
Trade value
$211.36K
% of position
0.5%
6/5/2026
1.18M→1.18M
Total
Net shares
+6.89K
Net value
-$211.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/5/2026 | M · Option Exercise | +13.04K | — | — | 1.1% | 1.17M | 1.18M |
| Ordinary Shares Direct | 6/5/2026 | S · Sale | −6.15K | $34.35 | $211.36K | 0.5% | 1.18M | 1.18M |
| Total | +6.89K | -$211.36K | ||||||
Derivative Transactions1
Restricted Share Units
Direct
Converts to
Ordinary Shares
13.04K shares
Shares
−13.04K
Strike price
Held after
39.13K
Exercisable
—
6/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Share Units Direct | Ordinary Shares13.04K shares | 6/5/2026 | M · Option Exercise | −13.04K | — | 39.13K |